In the tumor microenvironment, Gal-1’s upregulation benefits the tumor growth and reinforces the tumor progression by the modulation of cell motility [33], inducing apoptosis of activated T cells [34], mediation of cell adhesion [35], and participation in tumor angiogenesis [36]. The gene discussed is LGALS1; the disease is neoplasm.